XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of Grant Date Fair Value of Stock Options Issued

The significant inputs utilized to determine the grant date fair value of stock options issued during the six month periods ended June 30, 2025 and 2024 were as follows:

 

   June 30,   June 30, 
   2025   2024 
Dividend Yield   0%   0 %
Weighted average expected term (years)   5.38    5.75-6  
Volatility   101.98%   97.3-105.8 %
Risk-free rate   4.18%   4.10 %
Weighted average exercise price  $0.97   $1.33  
Schedule of Stock Option Activity

A summary of stock option activity for the six months ended June 30, 2025 is presented below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Contractual Term (Years)   Aggregate Intrinsic Value 
Outstanding as of December 31, 2024   10,633,988    1.02    6.25   $102,921,147 
Granted   250,000    0.97           
Exercised   -    -           
Forfeited   -    -           
Outstanding as of June 30, 2025   10,883,988   $1.02    5.61   $1,772,167 
Exercisable as of June 30, 2025   10,426,478   $1.01    5.48   $1,762,791 
Schedule of Employee Stock Options Outstanding

The following table summarizes information related to stock options outstanding as of June 30, 2025:

 

      Outstanding Options    Vested Options 
 Exercise Price    

Number

Outstanding at June 30, 2025

    Weighted Average Remaining Life    

Number Exercisable

at June 30, 2025

    Weighted Average Remaining Life 
$0.01    675,000    0.75    675,000    0.50 
$0.74    1,657,564    3.57    1,657,564    3.57 
$0.80    2,783,239    3.80    2,783,239    3.80 
$0.97    250,000    9.92    62,500    9.92 
$1.33    5,461,935    7.58    5,191,925    7.57 
$2.16    56,250    5.96    56,250    5.96 
      10,883,988    5.61    10,426,478    5.48 
Schedule of Warrant Activity

The following is a summary of the Company’s warrant activity for the six months ended June 30, 2025:

 

   Number of Shares   Weighted Average Exercise Price per Share   Weighted Average Remaining Life (Years) 
Outstanding as of December 31, 2024   1,359,375   $0.80    0.93 
Granted   -    -    - 
Forfeited   -   -    - 
Outstanding as of June 30, 2025   1,359,375   $0.80    0.51